InMed Pharmaceuticals Inc.
Index- P/E- EPS (ttm)-1.37 Insider Own0.78% Shs Outstand14.15M Perf Week36.75%
Market Cap124.54M Forward P/E- EPS next Y-0.35 Insider Trans25.83% Shs Float- Perf Month-13.94%
Income- PEG- EPS next Q-0.22 Inst Own9.05% Short Float- Perf Quarter-47.86%
Sales0.57M P/S216.71 EPS this Y34.20% Inst Trans- Short Ratio0.19 Perf Half Y-51.45%
Book/sh1.47 P/B5.97 EPS next Y51.00% ROA- Target Price3.40 Perf Year-84.42%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range5.82 - 59.25 Perf YTD-73.13%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-84.07% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low62.09% ATR1.46
Employees13 Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)55.64 Volatility33.39% 16.65%
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume46.96 Prev Close8.80
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume35.45K Price9.44
Recom3.00 SMA2013.00% SMA50-2.38% SMA200-56.88% Volume330,635 Change7.25%
Aug-23-22 05:00PM  
Aug-09-22 07:30AM  
Jul-25-22 07:30AM  
Jul-18-22 07:30AM  
Jul-12-22 11:33PM  
Jun-14-22 07:30AM  
Jun-09-22 07:30AM  
Jun-06-22 06:49PM  
Jun-02-22 08:00AM  
May-13-22 08:45AM  
May-05-22 07:30AM  
May-03-22 12:00PM  
Apr-28-22 07:30AM  
Apr-21-22 07:30AM  
Apr-19-22 07:30AM  
Mar-17-22 07:30AM  
Mar-08-22 07:30AM  
Feb-16-22 07:30AM  
Feb-15-22 07:30AM  
Feb-14-22 08:45PM  
Feb-10-22 07:30AM  
Jan-19-22 07:30AM  
Jan-05-22 07:30AM  
Dec-30-21 07:30AM  
Dec-20-21 07:30AM  
Dec-17-21 07:57PM  
Nov-23-21 07:30AM  
Nov-18-21 12:23PM  
Nov-17-21 08:25AM  
Nov-10-21 09:05AM  
Nov-03-21 07:30AM  
Oct-22-21 12:48PM  
Oct-18-21 07:02AM  
Oct-15-21 11:14AM  
Oct-13-21 04:30PM  
Sep-30-21 08:46AM  
Sep-24-21 12:31PM  
Sep-20-21 07:50AM  
Sep-17-21 01:14PM  
Sep-13-21 11:47AM  
Sep-09-21 07:18PM  
Sep-07-21 04:04PM  
Sep-03-21 08:35AM  
Sep-02-21 08:35AM  
Aug-25-21 01:27PM  
Aug-12-21 12:00PM  
Jul-02-21 04:15PM  
Jun-29-21 07:00AM  
Jun-28-21 08:35AM  
Jun-22-21 12:29PM  
Jun-21-21 08:35AM  
Jun-17-21 07:30AM  
Jun-15-21 06:41AM  
Jun-09-21 11:30AM  
May-13-21 09:15AM  
May-06-21 07:30AM  
May-04-21 07:30AM  
Apr-28-21 07:30AM  
Apr-27-21 07:30AM  
Apr-26-21 07:30AM  
Mar-17-21 02:49PM  
Mar-03-21 06:00PM  
Feb-26-21 08:00AM  
Feb-16-21 07:30AM  
Feb-11-21 09:30AM  
Feb-08-21 07:04AM  
Feb-05-21 09:00PM  
Feb-02-21 07:00AM  
Feb-01-21 05:00AM  
Jan-26-21 08:00AM  
Jan-19-21 02:00PM  
Jan-18-21 07:00AM  
Jan-08-21 07:30AM  
Jan-05-21 04:52PM  
Dec-11-20 07:00AM  
Nov-25-20 07:30AM  
Nov-24-20 08:00PM  
Nov-18-20 07:30AM  
InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in preclinical studies for the treatment of glaucoma; and INM-405 for the treatment of pain. In addition, it engages in the development of cannabinoid-based treatments for various diseases, including dermatology and ocular diseases. Further, the company works on IND-enabling pharmacology and preclinical toxicology studies; and IntegraSyn, an integrated biosynthesis-based manufacturing approach, for synthesizing pharmaceutical-grade cannabinoids. It has a research collaboration agreement with BayMedica Inc. for the manufacturing and testing of novel cannabinoid therapeutics. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is headquartered in Vancouver, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ADAMS ERIC APresident & CEOApr 14Buy0.8914,16012,65959,003Apr 18 11:46 AM
ADAMS ERIC APresident & CEOApr 13Buy0.858,5607,27644,843Apr 13 09:43 PM
COLWILL BRUCECFOJan 24Buy1.095,0005,43811,515Jan 24 02:02 PM
Johnson Shane AaronSVP, GM of BayMedica LLCJan 06Buy1.268,50010,710304,595Jan 06 06:40 PM
Johnson Shane AaronSVP, GM of BayMedica LLCDec 30Buy1.338,09310,736296,095Dec 30 07:22 PM
Johnson Shane AaronSVP, GM of BayMedica LLCNov 15Buy1.375,0006,845288,002Nov 15 03:33 PM
ADAMS ERIC APresident & CEOSep 29Buy1.738,80015,22436,283Sep 30 01:39 PM
ADAMS ERIC APresident & CEOSep 28Buy1.7511,40019,98427,483Sep 29 02:00 PM
COLWILL BRUCECFOSep 28Buy1.775,0008,8406,515Sep 29 01:59 PM